Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Caribou Biosciences (CRBU) Treasury Shares: 2022-2024

Historic Treasury Shares for Caribou Biosciences (CRBU) over the last 3 years, with Dec 2024 value amounting to $1.3 million.

  • Caribou Biosciences' Treasury Shares rose 71.14% to $2.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.2 million, marking a year-over-year increase of 71.14%. This contributed to the annual value of $1.3 million for FY2024, which is 531.74% up from last year.
  • According to the latest figures from FY2024, Caribou Biosciences' Treasury Shares is $1.3 million, which was up 531.74% from $205,357 recorded in FY2023.
  • In the past 5 years, Caribou Biosciences' Treasury Shares registered a high of $1.3 million during FY2024, and its lowest value of $205,357 during FY2023.
  • Its 3-year average for Treasury Shares is $586,277, with a median of $256,146 in 2022.
  • Its Treasury Shares has fluctuated over the past 5 years, first declined by 19.83% in 2023, then soared by 531.74% in 2024.
  • Caribou Biosciences' Treasury Shares (Yearly) stood at $256,146 in 2022, then decreased by 19.83% to $205,357 in 2023, then spiked by 531.74% to $1.3 million in 2024.